Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis (Genetics in Medicine, (2019), 21, 1, (44-52), 10.1038/gim.2018.31)

Hiroki Maruyama; Kaori Miyata; Mariko Mikame; Atsumi Taguchi; Chu Guili; Masaru Shimura; Kei Murayama; Takeshi Inoue; Saori Yamamoto; Koichiro Sugimura; Koichi Tamita; Toshihiro Kawasaki; Jun Kajihara; Akifumi Onishi; Hitoshi Sugiyama; Teiko Sakai; Ichijiro Murata; Takamasa Oda; Shigeru Toyoda; Kenichiro Hanawa; Takeo Fujimura; Shigehisa Ura; Mimiko Matsumura; Hideki Takano; Satoshi Yamashita; Gaku Matsukura; Ryushi Tazawa; Tsuyoshi Shiga; Mio Ebato; Hiroshi Satoh; Satoshi Ishii

doi:10.1038/s41436-019-0447-8

Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis (Genetics in Medicine, (2019), 21, 1, (44-52), 10.1038/gim.2018.31)

Hiroki Maruyama^*, Kaori Miyata, Mariko Mikame, Atsumi Taguchi, Chu Guili, Masaru Shimura, Kei Murayama, Takeshi Inoue, Saori Yamamoto, Koichiro Sugimura, Koichi Tamita, Toshihiro Kawasaki, Jun Kajihara, Akifumi Onishi, Hitoshi Sugiyama, Teiko Sakai, Ichijiro Murata, Takamasa Oda, Shigeru Toyoda, Kenichiro HanawaTakeo Fujimura, Shigehisa Ura, Mimiko Matsumura, Hideki Takano, Satoshi Yamashita, Gaku Matsukura, Ryushi Tazawa, Tsuyoshi Shiga, Mio Ebato, Hiroshi Satoh, Satoshi Ishii

^*この論文の責任著者

薬剤部

研究成果: ジャーナルへの寄稿 › コメント/討論

抄録

The HTML version of this Article contained errors in Supplementary Figure S2 “Flowchart of the lyso-Gb3 screening and gene analysis in female patients”, which have been detailed in the associated Correction.

本文言語	英語
ページ（範囲）	1263
ページ数	1
ジャーナル	Genetics in Medicine
巻	21
号	5
DOI	https://doi.org/10.1038/s41436-019-0447-8
出版ステータス	出版済み - 2019/05/01

ASJC Scopus 主題領域

遺伝学（臨床）

文献へのアクセス

10.1038/s41436-019-0447-8

フィンガープリント

「Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis (Genetics in Medicine, (2019), 21, 1, (44-52), 10.1038/gim.2018.31)」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル

Maruyama, H., Miyata, K., Mikame, M., Taguchi, A., Guili, C., Shimura, M., Murayama, K., Inoue, T., Yamamoto, S., Sugimura, K., Tamita, K., Kawasaki, T., Kajihara, J., Onishi, A., Sugiyama, H., Sakai, T., Murata, I., Oda, T., Toyoda, S., ... Ishii, S. (2019). Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis (Genetics in Medicine, (2019), 21, 1, (44-52), 10.1038/gim.2018.31). Genetics in Medicine, 21(5), 1263. https://doi.org/10.1038/s41436-019-0447-8

@article{493740defafa47209d248cf2fa9f5f85,

title = "Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis (Genetics in Medicine, (2019), 21, 1, (44-52), 10.1038/gim.2018.31)",

abstract = "The HTML version of this Article contained errors in Supplementary Figure S2 “Flowchart of the lyso-Gb3 screening and gene analysis in female patients”, which have been detailed in the associated Correction.",

author = "Hiroki Maruyama and Kaori Miyata and Mariko Mikame and Atsumi Taguchi and Chu Guili and Masaru Shimura and Kei Murayama and Takeshi Inoue and Saori Yamamoto and Koichiro Sugimura and Koichi Tamita and Toshihiro Kawasaki and Jun Kajihara and Akifumi Onishi and Hitoshi Sugiyama and Teiko Sakai and Ichijiro Murata and Takamasa Oda and Shigeru Toyoda and Kenichiro Hanawa and Takeo Fujimura and Shigehisa Ura and Mimiko Matsumura and Hideki Takano and Satoshi Yamashita and Gaku Matsukura and Ryushi Tazawa and Tsuyoshi Shiga and Mio Ebato and Hiroshi Satoh and Satoshi Ishii",

note = "Publisher Copyright: {\textcopyright} 2019, American College of Medical Genetics and Genomics.",

year = "2019",

month = may,

day = "1",

doi = "10.1038/s41436-019-0447-8",

language = "英語",

volume = "21",

pages = "1263",

journal = "Genetics in Medicine",

issn = "1098-3600",

publisher = "Elsevier B.V.",

number = "5",

}

Maruyama, H, Miyata, K, Mikame, M, Taguchi, A, Guili, C, Shimura, M, Murayama, K, Inoue, T, Yamamoto, S, Sugimura, K, Tamita, K, Kawasaki, T, Kajihara, J, Onishi, A, Sugiyama, H, Sakai, T, Murata, I, Oda, T, Toyoda, S, Hanawa, K, Fujimura, T, Ura, S, Matsumura, M, Takano, H, Yamashita, S, Matsukura, G, Tazawa, R, Shiga, T, Ebato, M, Satoh, H & Ishii, S 2019, 'Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis (Genetics in Medicine, (2019), 21, 1, (44-52), 10.1038/gim.2018.31)', Genetics in Medicine, vol. 21, no. 5, pp. 1263. https://doi.org/10.1038/s41436-019-0447-8

Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis (Genetics in Medicine, (2019), 21, 1, (44-52), 10.1038/gim.2018.31). / Maruyama, Hiroki; Miyata, Kaori; Mikame, Mariko その他.
In: Genetics in Medicine, Vol. 21, No. 5, 01.05.2019, p. 1263.

研究成果: ジャーナルへの寄稿 › コメント/討論

TY - JOUR

T1 - Correction

T2 - Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis (Genetics in Medicine, (2019), 21, 1, (44-52), 10.1038/gim.2018.31)

AU - Maruyama, Hiroki

AU - Miyata, Kaori

AU - Mikame, Mariko

AU - Taguchi, Atsumi

AU - Guili, Chu

AU - Shimura, Masaru

AU - Murayama, Kei

AU - Inoue, Takeshi

AU - Yamamoto, Saori

AU - Sugimura, Koichiro

AU - Tamita, Koichi

AU - Kawasaki, Toshihiro

AU - Kajihara, Jun

AU - Onishi, Akifumi

AU - Sugiyama, Hitoshi

AU - Sakai, Teiko

AU - Murata, Ichijiro

AU - Oda, Takamasa

AU - Toyoda, Shigeru

AU - Hanawa, Kenichiro

AU - Fujimura, Takeo

AU - Ura, Shigehisa

AU - Matsumura, Mimiko

AU - Takano, Hideki

AU - Yamashita, Satoshi

AU - Matsukura, Gaku

AU - Tazawa, Ryushi

AU - Shiga, Tsuyoshi

AU - Ebato, Mio

AU - Satoh, Hiroshi

AU - Ishii, Satoshi

PY - 2019/5/1

Y1 - 2019/5/1

N2 - The HTML version of this Article contained errors in Supplementary Figure S2 “Flowchart of the lyso-Gb3 screening and gene analysis in female patients”, which have been detailed in the associated Correction.

AB - The HTML version of this Article contained errors in Supplementary Figure S2 “Flowchart of the lyso-Gb3 screening and gene analysis in female patients”, which have been detailed in the associated Correction.

UR - http://www.scopus.com/inward/record.url?scp=85065218334&partnerID=8YFLogxK

U2 - 10.1038/s41436-019-0447-8

DO - 10.1038/s41436-019-0447-8

M3 - コメント/討論

C2 - 30728527

AN - SCOPUS:85065218334

SN - 1098-3600

VL - 21

SP - 1263

JO - Genetics in Medicine

JF - Genetics in Medicine

IS - 5

ER -

Maruyama H, Miyata K, Mikame M, Taguchi A, Guili C, Shimura M その他. Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis (Genetics in Medicine, (2019), 21, 1, (44-52), 10.1038/gim.2018.31). Genetics in Medicine. 2019 5月 1;21(5):1263. doi: 10.1038/s41436-019-0447-8